Dr. Boris Nikolic, science advisor to none other than Bill Gates, is launching a new life sciences fund. Seattle-based Biomatics Capital Partners is looking to raise $150 million, according to a regulatory filing.
Nikolic, a Harvard physician with a background in immunology, advised Gates’ Catalyst 3 (bgc3) as well as the Bill and Melinda Gates Foundation. He led a $120 million round in which Gates and 12 other investors last August funded the hot CRISPR gene editing startup Editas Medicine. He also participated in a $61 million round this year for Twist Biosciences, a synthetic DNA startup.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Also on the regulatory filing is Julie Sunderland, who remains listed by the Emerging Markets Private Equity Association as the director of program-listed investments at the Bill and Melinda Gates Foundation.
Earlier this year, Biomatics was listed as an investor in the $12.25 million Series A round for AiCure, a New York-based artificial intelligence company that uses mobile tools to confirm patients have ingested their pills.
Photo: Getty Images